本页面由Tiger Trade Technology Pte. Ltd.提供服务

Oncolytics Biotech Inc

0.4733
-0.0837-15.03%
盘后:0.4603-0.0130-2.75%16:28 EDT
成交量:318.81万
成交额:159.57万
市值:6,200.23万
市盈率:-1.47
高:0.5895
开:0.5702
低:0.4414
收:0.5570
52周最高:1.32
52周最低:0.4414
股本:1.31亿
流通股本:1.27亿
量比:2.63
换手率:2.52%
股息:- -
股息率:- -
每股收益(TTM):-0.3215
每股收益(LYR):-0.3000
净资产收益率:-10187.64%
总资产收益率:-211.24%
市净率:-10.05
市盈率(LYR):-1.58

数据加载中...

2021/03/05

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/05

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/05

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/24

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/06

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]